_version_ 1784730653241114624
author Hong, Simon J.
Bhattacharya, Sumona
Aboubakr, Aiya
Nadkarni, Devika
Lech, Diana
Ungaro, Ryan C.
Agrawal, Manasi
Hirten, Robert
Greywoode, Ruby
Mone, Anjali
Chang, Shannon
Hudesman, David
Ullman, Thomas
Sultan, Keith S.
Lukin, Dana J.
Colombel, Jean Frederic
Axelrad, Jordan E.
author_facet Hong, Simon J.
Bhattacharya, Sumona
Aboubakr, Aiya
Nadkarni, Devika
Lech, Diana
Ungaro, Ryan C.
Agrawal, Manasi
Hirten, Robert
Greywoode, Ruby
Mone, Anjali
Chang, Shannon
Hudesman, David
Ullman, Thomas
Sultan, Keith S.
Lukin, Dana J.
Colombel, Jean Frederic
Axelrad, Jordan E.
author_sort Hong, Simon J.
collection PubMed
description
format Online
Article
Text
id pubmed-9212657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92126572022-06-22 Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT Hong, Simon J. Bhattacharya, Sumona Aboubakr, Aiya Nadkarni, Devika Lech, Diana Ungaro, Ryan C. Agrawal, Manasi Hirten, Robert Greywoode, Ruby Mone, Anjali Chang, Shannon Hudesman, David Ullman, Thomas Sultan, Keith S. Lukin, Dana J. Colombel, Jean Frederic Axelrad, Jordan E. Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212657/ http://dx.doi.org/10.1016/S0016-5085(22)61405-7 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Hong, Simon J.
Bhattacharya, Sumona
Aboubakr, Aiya
Nadkarni, Devika
Lech, Diana
Ungaro, Ryan C.
Agrawal, Manasi
Hirten, Robert
Greywoode, Ruby
Mone, Anjali
Chang, Shannon
Hudesman, David
Ullman, Thomas
Sultan, Keith S.
Lukin, Dana J.
Colombel, Jean Frederic
Axelrad, Jordan E.
Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
title Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
title_full Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
title_fullStr Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
title_full_unstemmed Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
title_short Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
title_sort su1483: covid-19 vaccines are highly effective in patients with ibd: outcomes from the scout ibd cohort
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212657/
http://dx.doi.org/10.1016/S0016-5085(22)61405-7
work_keys_str_mv AT hongsimonj su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT bhattacharyasumona su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT aboubakraiya su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT nadkarnidevika su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT lechdiana su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT ungaroryanc su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT agrawalmanasi su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT hirtenrobert su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT greywooderuby su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT moneanjali su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT changshannon su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT hudesmandavid su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT ullmanthomas su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT sultankeiths su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT lukindanaj su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT colombeljeanfrederic su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort
AT axelradjordane su1483covid19vaccinesarehighlyeffectiveinpatientswithibdoutcomesfromthescoutibdcohort